Our findings of an age-dependent decline in CFTR function in people without CF may therefore contribute to an increased risk of developing CRC in older people as the majority of CRC patients are diagnosed after the age of 65 years (Siegel et al., 2023). The gene discussed is CFTR; the disease is colorectal carcinoma.